Patents by Inventor Martin Lawson

Martin Lawson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS AND METHODS FOR INHIBITING EMT PATHWAYS TO TREAT CANCER, ORGAN FIBROSIS AND METABOLIC DISORDERS
    Publication number: 20220017466
    Abstract: A compound, or a pharmaceutically acceptable salt or isomer thereof, of Formula I: wherein R is hydrogen, alkyl, substituted alkyl, alkenyl, or substituted alkenyl; R1 is hydrogen, alkoxy, or substituted alkoxy; R2 is hydrogen, alkyl, or substituted alkyl; and R3 is hydrogen, alkyl, or substituted alkyl.
    Type: Application
    Filed: June 25, 2021
    Publication date: January 20, 2022
    Applicants: University of Pittsburgh - Of the Commonwealth System of Higher Education, Universite Le Havre Normandie
    Inventors: Abdelhadi Rebbaa, Sebastien Comesse, Adam Daich, Martin Lawson, Catalin Pintiala
  • Compounds and methods for inhibiting EMT pathways to treat cancer, organ fibrosis and metabolic disorders
    Patent number: 11078159
    Abstract: A compound, or a pharmaceutically acceptable salt or isomer thereof, of Formula I: wherein R is hydrogen, alkyl, substituted alkyl, alkenyl, or substituted alkenyl; R1 is hydrogen, alkoxy, or substituted alkoxy; R2 is hydrogen, alkyl, or substituted alkyl; and R3 is hydrogen, alkyl, or substituted alkyl.
    Type: Grant
    Filed: February 19, 2018
    Date of Patent: August 3, 2021
    Assignees: University of Pittsburgh—Of the Commonwealth System of Higher Education, Universite Le Havre Normandie
    Inventors: Abdelhadi Rebbaa, Sebastien Comesse, Adam Daich, Martin Lawson, Catalin Pintiala
  • COMPOUNDS AND METHODS FOR INHIBITING EMT PATHWAYS TO TREAT CANCER, ORGAN FIBROSIS AND METABOLIC DISORDERS
    Publication number: 20190375710
    Abstract: A compound, or a pharmaceutically acceptable salt or isomer thereof, of Formula I: wherein R is hydrogen, alkyl, substituted alkyl, alkenyl, or substituted alkenyl; R1 is hydrogen, alkoxy, or substituted alkoxy; R2 is hydrogen, alkyl, or substituted alkyl; and R3 is hydrogen, alkyl, or substituted alkyl.
    Type: Application
    Filed: February 19, 2018
    Publication date: December 12, 2019
    Applicants: University of Pittsburgh - Of the Commonwealth System of Higher Education, Universite Le Havre Normandie
    Inventors: Abdelhadi Rebbaa, Sebastien Comesse, Adam Daich, Martin Lawson, Catalin Pintiala